Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Show more
CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance with Nasdaq for continued...
CAMBRIDGE, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) today announced the successful completion of a comprehensive financial...
CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) and Factor Bioscience Limited (“Factor”) today announced an exclusive...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.19 | -17.4311926606 | 1.09 | 1.46 | 0.835 | 25297 | 1.00092604 | CS |
4 | -0.2 | -18.1818181818 | 1.1 | 1.46 | 0.8349 | 32787 | 1.01724124 | CS |
12 | -0.96 | -51.6129032258 | 1.86 | 1.92 | 0.8349 | 35196 | 1.13687554 | CS |
26 | -1.45 | -61.7021276596 | 2.35 | 2.625 | 0.8349 | 20486 | 1.30030082 | CS |
52 | -0.23 | -20.3539823009 | 1.13 | 2.625 | 0.8349 | 20790 | 1.43242343 | CS |
156 | -3.3 | -78.5714285714 | 4.2 | 7.15 | 0.8349 | 33450 | 3.39223536 | CS |
260 | -3.3 | -78.5714285714 | 4.2 | 7.15 | 0.8349 | 33450 | 3.39223536 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales